1039 related articles for article (PubMed ID: 16160738)
1. Identification of osteopenic women at high risk of fracture: the OFELY study.
Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
[TBL] [Abstract][Full Text] [Related]
2. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
[TBL] [Abstract][Full Text] [Related]
3. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
[TBL] [Abstract][Full Text] [Related]
5. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
[TBL] [Abstract][Full Text] [Related]
6. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.
Sornay-Rendu E; Boutroy S; Munoz F; Delmas PD
J Bone Miner Res; 2007 Mar; 22(3):425-33. PubMed ID: 17181395
[TBL] [Abstract][Full Text] [Related]
7. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
Garnero P; Delmas PD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
[TBL] [Abstract][Full Text] [Related]
8. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
Sornay-Rendu E; Munoz F; Delmas PD; Chapurlat RD
J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
[TBL] [Abstract][Full Text] [Related]
9. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
[TBL] [Abstract][Full Text] [Related]
10. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
[TBL] [Abstract][Full Text] [Related]
11. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
12. Residual lifetime risk of fractures in women and men.
Nguyen ND; Ahlborg HG; Center JR; Eisman JA; Nguyen TV
J Bone Miner Res; 2007 Jun; 22(6):781-8. PubMed ID: 17352657
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
[TBL] [Abstract][Full Text] [Related]
14. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis and fracture risk in women of different ethnic groups.
Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
[TBL] [Abstract][Full Text] [Related]
16. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Watts NB; Geusens P; Barton IP; Felsenberg D
J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
[TBL] [Abstract][Full Text] [Related]
17. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ
Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
[TBL] [Abstract][Full Text] [Related]
19. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
20. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele.
Yazdanpanah N; Uitterlinden AG; Zillikens MC; Jhamai M; Rivadeneira F; Hofman A; de Jonge R; Lindemans J; Pols HA; van Meurs JB
J Bone Miner Res; 2008 Jan; 23(1):86-94. PubMed ID: 17725378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
